Last year, Teva Pharmaceuticals signed a major lease deal at 400 Interpace Parkway in Parsippany, NJ.
WEST CHESTER, PA—Teva Pharmaceuticals USA, Inc. reports that by acquiring three buildings on Brandywine Parkway here, it has created a North America Research & Development campus.
The firm has acquired 400, 500 and 600 Brandywine Parkway, which the company had been leasing since 2007. Its new holdings, along with 100, 200 and 300 Brandywine Parkway, which it already owned, increases its campus to approximately 314,000 square feet in West Chester.
Recommended For You
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
John Jordan
John Jordan is a veteran journalist with 36 years of print and digital media experience.
